Exxua, a Novel Treatment for Major Depressive Disorder, Gets FDA Approval
The FDA has approved Exxua (gepirone HCl extended-release tablets) for the treatment of major depressive disorder in adults.
Source: empr.com
Page 35 - Boxed Warning News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Boxed Warning. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Boxed Warning Today - Breaking & Trending Today
FDA Approves Gepirone Hydrochloride Tablets for Major Depression
The indication is the first for an antidepressant that selectively targets the serotonin 1A receptor—a regulator of mood and emotion.
Source: hcplive.com
Delcath Systems Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
/PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH) (the "Company" or "Delcath"), an interventional oncology company focused on the treatment of primary and...
Source: prnewswire.com
Delcath Systems Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Delcath Systems, Inc. (the "Company" or "Delcath"), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announces that the Company granted equity awards, in the form of a total of 86,000 shares...
Source: lelezard.com
Allergan Aesthetics Announces Positive Topline Results from Second Phase 3 Study of OnabotulinumtoxinA (BOTOX® Cosmetic) for the Treatment of Platysma Prominence
/PRNewswire/ -- Allergan Aesthetics, an AbbVie company (NYSE: ABBV), today announced positive topline results from the second of three Phase 3 clinical studies...
Source: prnewswire.com